SBIR/STTR Research Award

Modeling the Structure-Activity of Chemokine Receptors

Award identifier 6b2b601b25afc0458a0d856f7ae04a1b547bf6a4c43e0344a543a758d08e2654Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$222,303

Program and phase

SBIR · Phase I

Award year

2006

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
INTEGRAL MOLECULAR INC
Proposal award date
Not reported
Contract end date
Not reported
UEI
DY9KSWE8EJB8
Solicitation number
PHS2006-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Understanding the precise molecular interactions between drugs and their targets, their structure-activity relationship (SAR), is a highly desirable goal during drug development. Elucidation of SAR for G protein-coupled receptors (GPCRs) is a complicated task because direct structural visualization of these proteins is difficult or impossible. We have created a product, the Structure-Activity Relationship Array (SARray), that enables structural and functional interactions of drug candidates with GPCRs to be determined at the detailed level of amino acid side-chain interactions. The primary goal of this proposal is to create a tool that will facilitate drug optimization for GPCRs. The prototype SARray, developed and tested in Phase 1, will focus on the chemokine receptor CCR5. SARrays for all twenty chemokine receptors will be developed in Phase 2, and customized SARrays for any membrane protein will be offered in Phase 3. These arrays (our physical product) will be sent to customers with protocols and support for array analysis and processing. In preliminary experiments, we created a prototype CCR5 SARray. The SARray was rapidly assayed for five different functions, including evaluation of antibody binding epitopes and HIV-1 coreceptor function. Relevant molecular interactions were identified, even within our small-scale library, suggesting that our strategy for SAR analysis of GPCRs can be accomplished. The Specific Aims of our Phase I proposal are: Specific Aim I. Create a Comprehensive SARray in which the Functional Role of Every Amino Acid of a GPCR can be Assayed. Specific Aim II. Analyze Structure-Activity Relationships of a GPCR.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

48 SBIR/STTR records share this UEI (2002–2025). Reported award amounts total $32,839,788. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.